Please login to the form below

Not currently logged in
Email:
Password:

Cirara

This page shows the latest Cirara news and features for those working in and with pharma, biotech and healthcare.

Biogen wins European spinal muscular atrophy first

Biogen wins European spinal muscular atrophy first

To that end it recently bought late-stage stroke candidate Cirara (glyburide) from Remedy Pharma and an anti-tau antibody from Bristol-Myers Squibb for Alzheimer's disease.

Latest news

  • Biogen hands out $120m upfront for Remedy stroke drug Biogen hands out $120m upfront for Remedy stroke drug

    Biogen hands out $120m upfront for Remedy stroke drug. Cirara vying to be first new treatment since the 1990s. ... Cirara (RP-1127) is an intravenous formulation of glyburide, a drug better known for its longstanding use as an oral treatment for type 2

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics